As noted in our prior studies of obesity in CHS and ADNI (Ho et al., 2010), the CHS cohort tends to have a higher prevalence of vascular disease and ApoE4 genotypes than ADNI, and there are demographic differences too. This evidence concerns the gene APOE and obesity due to melanocortin 4 receptor deficiency.